Cargando…
Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists
BACKGROUND: There is emerging evidence that Wnt pathway activity may increase during the progression from colorectal adenoma to carcinoma and that this increase is potentially an important step towards the invasive stage. Here, we investigated whether epigenetic silencing of Wnt antagonists is the b...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265460/ https://www.ncbi.nlm.nih.gov/pubmed/25432628 http://dx.doi.org/10.1186/1471-2407-14-891 |
_version_ | 1782348894800183296 |
---|---|
author | Silva, Ana-Luisa Dawson, Sarah N Arends, Mark J Guttula, Kiran Hall, Nigel Cameron, Ewen A Huang, Tim H-M Brenton, James D Tavaré, Simon Bienz, Mariann Ibrahim, Ashraf EK |
author_facet | Silva, Ana-Luisa Dawson, Sarah N Arends, Mark J Guttula, Kiran Hall, Nigel Cameron, Ewen A Huang, Tim H-M Brenton, James D Tavaré, Simon Bienz, Mariann Ibrahim, Ashraf EK |
author_sort | Silva, Ana-Luisa |
collection | PubMed |
description | BACKGROUND: There is emerging evidence that Wnt pathway activity may increase during the progression from colorectal adenoma to carcinoma and that this increase is potentially an important step towards the invasive stage. Here, we investigated whether epigenetic silencing of Wnt antagonists is the biological driver for this increased Wnt activity in human tissues and how these methylation changes correlate with MSI (Microsatelite Instability) and CIMP (CpG Island Methylator Phenotype) statuses as well as known mutations in genes driving colorectal neoplasia. METHODS: We conducted a systematic analysis by pyrosequencing, to determine the promoter methylation of CpG islands associated with 17 Wnt signaling component genes. Methylation levels were correlated with MSI and CIMP statuses and known mutations within the APC, BRAF and KRAS genes in 264 matched samples representing the progression from normal to pre-invasive adenoma to colorectal carcinoma. RESULTS: We discovered widespread hypermethylation of the Wnt antagonists SFRP1, SFRP2, SFRP5, DKK2, WIF1 and SOX17 in the transition from normal to adenoma with only the Wnt antagonists SFRP1, SFRP2, DKK2 and WIF1 showing further significant increase in methylation from adenoma to carcinoma. We show this to be accompanied by loss of expression of these Wnt antagonists, and by an increase in nuclear Wnt pathway activity. Mixed effects models revealed that mutations in APC, BRAF and KRAS occur at the transition from normal to adenoma stages whilst the hypermethylation of the Wnt antagonists continued to accumulate during the transitions from adenoma to carcinoma stages. CONCLUSION: Our study provides strong evidence for a correlation between progressive hypermethylation and silencing of several Wnt antagonists with stepping-up in Wnt pathway activity beyond the APC loss associated tumour-initiating Wnt signalling levels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-891) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4265460 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42654602014-12-15 Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists Silva, Ana-Luisa Dawson, Sarah N Arends, Mark J Guttula, Kiran Hall, Nigel Cameron, Ewen A Huang, Tim H-M Brenton, James D Tavaré, Simon Bienz, Mariann Ibrahim, Ashraf EK BMC Cancer Research Article BACKGROUND: There is emerging evidence that Wnt pathway activity may increase during the progression from colorectal adenoma to carcinoma and that this increase is potentially an important step towards the invasive stage. Here, we investigated whether epigenetic silencing of Wnt antagonists is the biological driver for this increased Wnt activity in human tissues and how these methylation changes correlate with MSI (Microsatelite Instability) and CIMP (CpG Island Methylator Phenotype) statuses as well as known mutations in genes driving colorectal neoplasia. METHODS: We conducted a systematic analysis by pyrosequencing, to determine the promoter methylation of CpG islands associated with 17 Wnt signaling component genes. Methylation levels were correlated with MSI and CIMP statuses and known mutations within the APC, BRAF and KRAS genes in 264 matched samples representing the progression from normal to pre-invasive adenoma to colorectal carcinoma. RESULTS: We discovered widespread hypermethylation of the Wnt antagonists SFRP1, SFRP2, SFRP5, DKK2, WIF1 and SOX17 in the transition from normal to adenoma with only the Wnt antagonists SFRP1, SFRP2, DKK2 and WIF1 showing further significant increase in methylation from adenoma to carcinoma. We show this to be accompanied by loss of expression of these Wnt antagonists, and by an increase in nuclear Wnt pathway activity. Mixed effects models revealed that mutations in APC, BRAF and KRAS occur at the transition from normal to adenoma stages whilst the hypermethylation of the Wnt antagonists continued to accumulate during the transitions from adenoma to carcinoma stages. CONCLUSION: Our study provides strong evidence for a correlation between progressive hypermethylation and silencing of several Wnt antagonists with stepping-up in Wnt pathway activity beyond the APC loss associated tumour-initiating Wnt signalling levels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-891) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-29 /pmc/articles/PMC4265460/ /pubmed/25432628 http://dx.doi.org/10.1186/1471-2407-14-891 Text en © Silva et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Silva, Ana-Luisa Dawson, Sarah N Arends, Mark J Guttula, Kiran Hall, Nigel Cameron, Ewen A Huang, Tim H-M Brenton, James D Tavaré, Simon Bienz, Mariann Ibrahim, Ashraf EK Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists |
title | Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists |
title_full | Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists |
title_fullStr | Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists |
title_full_unstemmed | Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists |
title_short | Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists |
title_sort | boosting wnt activity during colorectal cancer progression through selective hypermethylation of wnt signaling antagonists |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265460/ https://www.ncbi.nlm.nih.gov/pubmed/25432628 http://dx.doi.org/10.1186/1471-2407-14-891 |
work_keys_str_mv | AT silvaanaluisa boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists AT dawsonsarahn boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists AT arendsmarkj boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists AT guttulakiran boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists AT hallnigel boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists AT cameronewena boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists AT huangtimhm boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists AT brentonjamesd boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists AT tavaresimon boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists AT bienzmariann boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists AT ibrahimashrafek boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists |